home.aspx

 
.

IMPLEMENTING BYOD ACROSS PHASE II AND III CLINICAL TRIALS

March 20, 2019 | (11:00 AM)
USA (United States of America)
The significant advantages for electronic patient-reported outcomes (ePRO) over paper records include improved compliance, data quality, and patient experiences – these advantages will best be realized only when Bring Your Own Device (BYOD) for the collection of patient-reported outcomes is deployed across all trial phases. In practice, however, implementation of BYOD has been mostly isolated to Phase I and Phase IV trials. Regardless, there are real opportunities now for bringing the promise of BYOD to Phase II and III. This webinar will review strategies and outcomes from a recent Phase III study supported by Clinical Ink, where BYOD was leveraged by 90 percent of its patient population for the collection of primary endpoint data, achieving a compliance rate well over 90 percent. The featured speaker in this webinar will also provide real-world examples for how other Phase II and III studies can also use BYOD for data collection.